|
Implant Biofilm Mediated Immune Response |
1R01AI165958-01A1 |
|
NIAID |
2022 |
|
Novel Biofilm Paradigm Explaining Clinical Implant-Associated Illness. |
1R21AI171932-01 |
|
NIAID |
2022 |
|
Nanoimmunotherapy for chronic immune-mediated diseases |
1R41AI170413-01 |
|
NIAID |
2022 |
|
Human antibody modification of enterovirus D68 infection |
5K08AI156125-02 |
|
NIAID |
2022 |
|
Biomaterials to study tolerance immune induction kinetics |
5R01AI137525-05 |
|
NIAID |
2022 |
|
Translational approaches to improve understanding and outcome in Tuberculous meningitis |
5R01AI145436-03 |
|
NIAID |
2022 |
|
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity |
5R01AI148711-03 |
|
NIAID |
2022 |
|
ThGM Cells in CNS Autoimmunity |
5R01AI155974-02 |
|
NIAID |
2022 |
|
Role of IL-7R in CNS autoimmunity |
5R01AI156384-02 |
|
NIAID |
2022 |
|
IL-37: a novel regulator of inflammation in CNS autoimmunity |
5R01AI160189-02 |
|
NIAID |
2022 |